Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]
Omboni S, Malacco E, Mallion JM, Volpe M. Clinical Interventions in Aging. 2015;10:1575–1586.On page 1584, left column, 4th row from the bottom, the age indicated should be 65–69 rather than 65–59.Read the original article
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e7bad196d9a545c6b5c2eb61d5934d8b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e7bad196d9a545c6b5c2eb61d5934d8b |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e7bad196d9a545c6b5c2eb61d5934d8b2021-12-02T06:56:30ZOlmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]1178-1998https://doaj.org/article/e7bad196d9a545c6b5c2eb61d5934d8b2017-08-01T00:00:00Zhttps://www.dovepress.com/corrigendum-olmesartan-vs-ramipril-in-the-treatment-of-hypertensi-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Omboni S, Malacco E, Mallion JM, Volpe M. Clinical Interventions in Aging. 2015;10:1575–1586.On page 1584, left column, 4th row from the bottom, the age indicated should be 65–69 rather than 65–59.Read the original articleOmboni SMalacco EMallion JVolpe MDove Medical PressarticleGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 12, Pp 1205-1206 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Geriatrics RC952-954.6 |
| spellingShingle |
Geriatrics RC952-954.6 Omboni S Malacco E Mallion J Volpe M Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] |
| description |
Omboni S, Malacco E, Mallion JM, Volpe M. Clinical Interventions in Aging. 2015;10:1575–1586.On page 1584, left column, 4th row from the bottom, the age indicated should be 65–69 rather than 65–59.Read the original article |
| format |
article |
| author |
Omboni S Malacco E Mallion J Volpe M |
| author_facet |
Omboni S Malacco E Mallion J Volpe M |
| author_sort |
Omboni S |
| title |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] |
| title_short |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] |
| title_full |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] |
| title_fullStr |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] |
| title_full_unstemmed |
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum] |
| title_sort |
olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [corrigendum] |
| publisher |
Dove Medical Press |
| publishDate |
2017 |
| url |
https://doaj.org/article/e7bad196d9a545c6b5c2eb61d5934d8b |
| work_keys_str_mv |
AT ombonis olmesartanvsramiprilinthetreatmentofhypertensionandassociatedclinicalconditionsintheelderlyareanalysisoftwolargedoubleblindrandomizedstudiesatthelightofthemostrecentbloodpressuretargetsrecommendedbyguidelinescorrigendum AT malaccoe olmesartanvsramiprilinthetreatmentofhypertensionandassociatedclinicalconditionsintheelderlyareanalysisoftwolargedoubleblindrandomizedstudiesatthelightofthemostrecentbloodpressuretargetsrecommendedbyguidelinescorrigendum AT mallionj olmesartanvsramiprilinthetreatmentofhypertensionandassociatedclinicalconditionsintheelderlyareanalysisoftwolargedoubleblindrandomizedstudiesatthelightofthemostrecentbloodpressuretargetsrecommendedbyguidelinescorrigendum AT volpem olmesartanvsramiprilinthetreatmentofhypertensionandassociatedclinicalconditionsintheelderlyareanalysisoftwolargedoubleblindrandomizedstudiesatthelightofthemostrecentbloodpressuretargetsrecommendedbyguidelinescorrigendum |
| _version_ |
1718399726205796352 |